These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15825179)

  • 1. SPOC1, a novel PHD-finger protein: association with residual disease and survival in ovarian cancer.
    Mohrmann G; Hengstler JG; Hofmann TG; Endele SU; Lee B; Stelzer C; Zabel B; Brieger J; Hasenclever D; Tanner B; Sagemueller J; Sehouli J; Will H; Winterpacht A
    Int J Cancer; 2005 Sep; 116(4):547-54. PubMed ID: 15825179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.
    Hengstler JG; Lange J; Kett A; Dornhöfer N; Meinert R; Arand M; Knapstein PG; Becker R; Oesch F; Tanner B
    Cancer Res; 1999 Jul; 59(13):3206-14. PubMed ID: 10397267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
    Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
    Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPOC1: a novel PHD-containing protein modulating chromatin structure and mitotic chromosome condensation.
    Kinkley S; Staege H; Mohrmann G; Rohaly G; Schaub T; Kremmer E; Winterpacht A; Will H
    J Cell Sci; 2009 Aug; 122(Pt 16):2946-56. PubMed ID: 19638409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
    Han L; Dong Z; Qiao Y; Kristensen GB; Holm R; Nesland JM; Suo Z
    Gynecol Oncol; 2005 Nov; 99(2):278-86. PubMed ID: 16061279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of H-Ryk in epithelial ovarian cancer: prognostic significance of receptor expression.
    Katso RM; Manek S; Ganjavi H; Biddolph S; Charnock MF; Bradburn M; Wells M; Ganesan TS
    Clin Cancer Res; 2000 Aug; 6(8):3271-81. PubMed ID: 10955813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.
    Sharma S; Qian F; Keitz B; Driscoll D; Scanlan MJ; Skipper J; Rodabaugh K; Lele S; Old LJ; Odunsi K
    Gynecol Oncol; 2005 Oct; 99(1):183-8. PubMed ID: 16005946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
    Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
    Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPOC1 (PHF13) is required for spermatogonial stem cell differentiation and sustained spermatogenesis.
    Bördlein A; Scherthan H; Nelkenbrecher C; Molter T; Bösl MR; Dippold C; Birke K; Kinkley S; Staege H; Will H; Winterpacht A
    J Cell Sci; 2011 Sep; 124(Pt 18):3137-48. PubMed ID: 21852425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenium binding protein 1 in ovarian cancer.
    Huang KC; Park DC; Ng SK; Lee JY; Ni X; Ng WC; Bandera CA; Welch WR; Berkowitz RS; Mok SC; Ng SW
    Int J Cancer; 2006 May; 118(10):2433-40. PubMed ID: 16380993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
    Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of astrocyte-elevated gene-1 is associated with ovarian cancer development and progression.
    Zhou B; Yang J; Shu B; Liu K; Xue L; Su N; Liu J; Xi T
    Mol Med Rep; 2015 Apr; 11(4):2981-90. PubMed ID: 25483832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
    Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
    Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.